News World Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients

Eli Lilly starts trial of rheumatoid arthritis drug in COVID-19 patients


Eli Lilly and Co on Monday said it was launching a study of its rheumatoid arthritis drug baricitinib in patients hospitalized for COVID-19.

The trial is one of several efforts by the U.S. drugmaker to help combat the coronavirus pandemic, which has killed more than 400,000 people globally, according to a Reuters tally.

The drug is being tested to see if it can reduce deaths from the COVID-19 illness and lessen its severity. Scientists at Lilly believe that baricitinib could help suppress a potentially lethal immune response to COVID-19 called “cytokine storm” and reduce COVID-19’s ability to reproduce in infected cells.

The trial began dosing patients last week and plans to enroll around 400 patients globally. Lilly could potentially obtain U.S. regulatory approval for the drug as soon as August, Patrik Jonsson, the president of Lilly Bio-Medicines, told Reuters in an interview.

Lilly has also been working with the National Institutes of Health to study baricitinib, which is branded Olumiant, in a pairing with Gilead Sciences Inc’s antiviral drug remdesivir. That study began enrolling patients last month.

The U.S. Food and Drug Administration granted Gilead’s remdesivir emergency use authorization (EUA) last month, citing results from a U.S. government study that showed the drug reduced hospitalization stays by 31%, or about four days, compared to a placebo.

Lilly could potentially receive approval to use baricitinib in combination with remdesivir by as early as July, Jonsson said.

Seperately, Lilly could have an drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters last week.


Top Stories

Cameroon man wanted in connection with attempted robbery (PHOTO)

Police are looking for Tima Acha Edwin, 32, from Cameroon, in connection with inquiries into a recent case of attempted robbery and gun and...

Belgium may need to return to full COVID lockdown

Belgium could be returning to full lockdown if there is no reversal of the surge in COVID-19 infections and hospital admissions, a senior Belgian...

“Flaming Arrow 2020” military exercise kicks off

The Mediterranean island's National Guard on Tuesday kicked-off a three-day military exercise code-named “Flaming Arrow 2020”. The Ministry of Defence said in a statement that...

Greece calls for suspension of EU-Turkey customs union

Greece has asked the European Commission to consider suspending a customs union agreement between Turkey and the European Union due to Ankara’s “continued provocations”...

UN chief to invite Cyprus leaders, guarantors to peace talks in November

UN Secretary-General Antonio Guterres is expected to call all interested parties in the Cyprus issue for a meeting in November now that leadership elections...


Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...


No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...